1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Hospital Care Partnering 2010-2016: Deal trends, players and financials

Global Hospital Care Partnering 2010 to 2016 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Hospital Care partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Hospital Care partnering agreement structure
Hospital Care partnering contract documents
Top Hospital Care deals by value
Most active Hospital Care dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.

The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Hospital Care dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Hospital Care dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Hospital Care deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Hospital Care dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Hospital Care deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Hospital Care partnering deals by specific Hospital Care target announced since 2010. The chapter is organized by specific Hospital Care therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Hospital Care partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Hospital Care partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Hospital Care technologies and products.


Report scope

Global Hospital Care Partnering 2010 to 2016 is intended to provide the reader with an in-depth understanding and access to Hospital Care trends and structure of deals entered into by leading companies worldwide.

Global Hospital Care Partnering 2010 to 2016 includes:

Trends in Hospital Care dealmaking in the biopharma industry since 2010
Analysis of Hospital Care deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Hospital Care deal contract documents
Comprehensive access to over 3500 Hospital Care deal records
The leading Hospital Care deals by value since 2010
Most active Hospital Care dealmakers since 2010

The report includes deals for the following indications: Accident and emergency, Rehabilitation medicine, Surgery, Orthopedics, Aesthetic procedures, Transplantation, plus other hospital care indications.

In Global Hospital Care Partnering 2010 to 2016, available deals and contracts are listed by:

Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Hospital care Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 1,500 hospital care deals.
Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Table Of Contents

Global Hospital Care Partnering 2010-2016: Deal trends, players and financials
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Hospital Care dealmaking

2.1. Introduction
2.2. Hospital Care partnering over the years
2.3. Hospital Care partnering by deal type
2.4. Hospital Care partnering by industry sector
2.5. Hospital Care partnering by stage of development
2.6. Hospital Care partnering by technology type
2.7. Hospital Care partnering by therapeutic indication

Chapter 3 -Financial deal terms for Hospital Care partnering

3.1. Introduction
3.2. Disclosed financials terms for Hospital Care partnering
3.3. Hospital Care partnering headline values
3.4. Hospital Care deal upfront payments
3.5. Hospital Care deal milestone payments
3.6. Hospital Care royalty rates

Chapter 4 - Leading Hospital Care deals and dealmakers

4.1. Introduction
4.2. Most active in Hospital Care partnering
4.3. List of most active dealmakers in Hospital Care
4.4. Top Hospital Care deals by value

Chapter 5 - Hospital Care contract document directory

5.1. Introduction
5.2. Hospital Care partnering deals where contract document available

Chapter 6 - Hospital Care dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Hospital Care therapeutic target

Appendices

Appendix 1 - Directory of Hospital Care deals by company A-Z 2010 to 2016
Appendix 2 - Directory of Hospital Care deals by deal type 2010 to 2016
Appendix 3 - Directory of Hospital Care deals by stage of development 2010 to 2016
Appendix 4 - Directory of Hospital Care deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering


Table of figures

Figure 1: Hospital Care partnering since 2010
Figure 2: Hospital Care partnering by deal type since 2010
Figure 3: Hospital Care partnering by industry sector since 2010
Figure 4: Hospital Care partnering by stage of development since 2010
Figure 5: Hospital Care partnering by technology type since 2010
Figure 6: Hospital Care partnering by indication since 2010
Figure 7: Hospital Care deals with a headline value
Figure 8: Hospital Care deals with upfront payment values
Figure 9: Hospital Care deals with milestone payment
Figure 10: Hospital Care deals with royalty rates
Figure 11: Active Hospital Care dealmaking activity- 2010 to 2016
Figure 12: Top Hospital Care deals by value since 2010

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.